Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.07 USD | +1.16% | +0.58% | -3.55% |
23/04 | Transcript : HealthStream, Inc., Q1 2024 Earnings Call, Apr 23, 2024 | |
22/04 | Earnings Flash (HSTM) HEALTHSTREAM Posts Q1 Revenue $72.8M, vs. Street Est of $71.9M | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 47.69 and 43.33 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.55% | 783M | C+ | ||
+8.73% | 313B | B- | ||
+21.67% | 211B | B+ | ||
+10.09% | 54.65B | D+ | ||
+4.40% | 30.8B | B+ | ||
-2.00% | 28.01B | C+ | ||
+19.42% | 19.93B | B- | ||
+62.80% | 18.79B | D+ | ||
+10.13% | 14.67B | B | ||
-0.98% | 14.58B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HSTM Stock
- Ratings HealthStream, Inc.